Drug intelligence / Profile preview

2-nonyl-4-quinolinol 1-oxide

Development stage: Unknown
Modality: Small Molecules

Overview

2-nonyl-4-quinolinol 1-oxide is a synthetic small molecule belonging to the hydroxyquinoline class. It features a quinoline ring substituted with a nonyl group at position 2 and an N–oxide functional group. The compound has demonstrated antimicrobial properties and is used in biochemical research as an experimental agent. Its mechanism of action is not fully elucidated but it is known for its activity against certain microorganisms[3][7]. There are no approved therapeutic indications or clinical uses for this compound as of now[1].

Other names: 2-nonyl-4-hydroxyquinoline N-oxidenonyl-4-hydroxyquinoline-N-oxidenonyl4-hydroxyquinoline-N-oxidenonyl 4-hydroxyquinoline-N-oxide1-hydroxy-2-nonylquinolin-4-one4-quinolinol, 2-nonyl-, 1-oxide

Targets

bc1 complex (Cytochrome bc1 complex (plasmodium))

Beyond the preview

Go deeper on 2-nonyl-4-quinolinol 1-oxide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-nonyl-4-quinolinol 1-oxide.

Explore the full profile